Whole-genome sequencing is still very expensive, but it is being used to make a difference in the lives of patients with rare diseases, says Richard Knox at the NPR Shots blog. Clinicians were able to treat Alexis and Noah Beery — 14-year-old twins afflicted with a rare disease called dopa-responsive dystonia — with a simple and effective therapy for their disease after they underwent whole-genome sequencing.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.